Asbestos Exposure Screening Programs - Revision history

MesotheliomaSupport: Fix broken internal link: Mesothelioma Diagnosis→Understanding Your Mesothelioma Diagnosis

2026-04-06T09:18:33Z

Fix broken internal link: Mesothelioma Diagnosis→Understanding Your Mesothelioma Diagnosis

← Older revision		Revision as of 09:18, 6 April 2026
Line 274:		Line 274:
	* [[Asbestos_Exposure]]		* [[Asbestos_Exposure]]
	* [[Mesothelioma_Blood_Tests_and_Biomarkers]]		* [[Mesothelioma_Blood_Tests_and_Biomarkers]]
	* [[~~Mesothelioma_Diagnosis~~]]		* [[Understanding Your Mesothelioma Diagnosis\|Mesothelioma Diagnosis]]
	* [[Pleural_Mesothelioma]]		* [[Pleural_Mesothelioma]]
	* [[Peritoneal_Mesothelioma]]		* [[Peritoneal_Mesothelioma]]

MesotheliomaSupport: Add differentiated triple GEO format

2026-03-09T03:51:53Z

Add differentiated triple GEO format

Show changes

MesotheliomaSupport: Remove H1, convert exec summary to lead, add listicle

2026-02-24T06:41:40Z

Remove H1, convert exec summary to lead, add listicle

← Older revision		Revision as of 06:41, 24 February 2026
Line 39:		Line 39:
	\|}		\|}

	= ~~Asbestos Exposure Screening Programs: How Early Detection Saves Lives Through Medical Surveillance~~ =		Asbestos-related diseases remain a '''major global public health burden''', with an estimated '''184,000 lung cancer deaths''' attributed to asbestos exposure worldwide each year. Because latency periods between first exposure and disease onset span '''20 to 50 years''', systematic screening and medical surveillance programs are essential for early detection in at-risk populations. The United States maintains a dual framework of '''mandatory OSHA workplace surveillance''' for currently exposed workers and voluntary screening programs for former workers, supplemented by emerging biomarker-based approaches and international models that continue to refine best practices.<ref name="pmc_ldct_screening" /><ref name="osha_surveillance" /><ref name="dandell_exposure" />

	== ~~Executive Summary =~~=		'''Low-dose computed tomography (LDCT)''' has demonstrated remarkable efficacy in detecting early-stage lung cancer among asbestos-exposed workers. The only mortality follow-up study conducted specifically in an asbestos-exposed population found a '''59% reduction in lung cancer mortality''' with LDCT screening compared to chest X-ray surveillance. The '''DOE Former Worker Medical Screening Program''' — the largest organized screening effort for asbestos-exposed workers in the United States — has conducted nearly '''40,000 medical screening examinations''' since 1996, detecting early-stage cancer in '''73%''' of screen-identified lung cancer cases.<ref name="oup_ldct_mortality" /><ref name="cpwr_btmed" /><ref name="mlc_asbestos" />

	~~Asbestos~~-related diseases ~~remain a major global public health burden~~, with ~~an estimated 184,000 lung cancer deaths attributed to [[Asbestos Exposure\|asbestos exposure]] worldwide each year. Because~~ latency periods ~~between first exposure and disease onset span 20 to 50~~ years, ~~systematic screening and medical surveillance programs are essential~~ for ~~early detection in at-risk populations. The United States maintains a dual framework of mandatory OSHA workplace surveillance~~ for ~~currently exposed workers~~ and ~~voluntary screening programs~~ for ~~former workers, supplemented by emerging biomarker-based approaches and international models that continue to refine best practices~~.<ref name="~~pmc_ldct_screening~~" /><ref name="~~osha_surveillance~~" /><ref name="~~dandell_exposure~~" />		A 27-year Italian health surveillance study of 1,405 former asbestos-exposed workers diagnosed asbestos-related diseases in '''24% of the cohort''', with average latency periods of 38 years for pleural plaques, 39 years for mesothelioma, 41 years for asbestosis, and 46 years for lung cancer.<ref name="pmc_italian_surveillance" /><ref name="mesonet_exposure" /><ref name="dandell_diagnosis" />

	~~Low-dose computed tomography (LDCT) has demonstrated remarkable efficacy in detecting early-stage lung cancer among asbestos-exposed workers~~. ~~The only mortality follow~~-~~up study conducted specifically in an asbestos~~-~~exposed population found a~~ 59% ~~reduction in~~ lung cancer mortality ~~with~~ LDCT screening ~~compared to~~ chest X-ray surveillance~~. The DOE Former Worker Medical Screening Program —~~ the ~~largest organized screening effort for~~ asbestos-~~exposed workers in the United States — has conducted nearly 40,000 medical screening examinations since 1996, detecting early~~-~~stage cancer in 73% of screen-identified lung cancer cases~~.<ref name="oup_ldct_mortality" /><ref name="cpwr_btmed" /><ref name="~~mlc_asbestos~~" />		'''Asbestos exposure screening programs at a glance:'''
			* '''OSHA PEL trigger: 0.1 fibers/cc''' — medical surveillance mandatory for all employees at or above this 8-hour time-weighted average exposure level<ref name="osha_surveillance" />
	~~A 27-year~~ Italian ~~health surveillance study of~~ 1,405 former ~~asbestos-exposed~~ workers ~~diagnosed asbestos-related diseases in 24% of the cohort, with average latency periods of 38~~ years ~~for pleural plaques~~, ~~39 years for [[Mesothelioma\|~~mesothelioma]], ~~41 years for asbestosis~~, and ~~46 years for~~ lung cancer~~. These findings underscore the critical importance~~ of ~~decades~~-~~long follow-up for exposed individuals. Current expert consensus recommends~~ LDCT ~~screening for workers aged~~ 50 ~~or older with at least~~ 5 years ~~of significant asbestos~~ exposure beginning 20 ~~or more~~ years ~~prior~~, ~~combined~~ with ~~either a~~ smoking history or additional risk factors ~~— criteria that capture substantially more~~ occupational lung cancers ~~than~~ smoking-~~based guidelines alone.~~<ref name="~~pmc_italian_surveillance~~" /><ref name="~~mesonet_exposure~~" /><ref name="~~dandell_diagnosis~~" />		* '''59% lung cancer mortality reduction''' — LDCT screening versus chest X-ray surveillance in the only asbestos-specific mortality follow-up study (HR 0.41)<ref name="oup_ldct_mortality" />
			* '''~40,000 DOE screenings since 1996''' — Building Trades Medical Screening Program across 35 DOE sites with 225+ credentialed clinics<ref name="cpwr_btmed" />
			* '''73% early-stage detection rate''' — screen-identified lung cancers found at treatable stages in the DOE Former Worker Program<ref name="doe_annual_report" />
			* '''24% disease rate in Italian cohort''' — 1,405 former workers followed for 27 years; asbestosis, mesothelioma, pleural plaques, and lung cancer diagnosed<ref name="pmc_italian_surveillance" />
			* '''B-reader certified radiologists required''' — ILO International Classification of Radiographs of Pneumoconioses standard for occupational chest X-ray interpretation<ref name="cdc_niosh" />
			* '''LDCT eligibility: age 50+, 5+ years exposure''' — expert consensus criteria beginning 20+ years from first exposure, with smoking history or additional risk factors<ref name="pmc_ldct_screening" />
			* '''USPSTF misses 40% of occupational lung cancers''' — smoking-only criteria failed to identify cancers in DOE construction workers with documented asbestos exposure<ref name="bmj_construction" />
			* '''MESOMARK: 32% sensitivity at 95% specificity''' — the only FDA-cleared mesothelioma biomarker, limited as a standalone screening tool<ref name="pmc_smrp_meta" />
			* '''Biennial LDCT cost-effective at 45,000 euro/QALY''' — for smokers with high asbestos exposure, below the standard 50,000 euro/QALY acceptability threshold<ref name="pmc_cost_effectiveness" />

	{\| class="wikitable" style="width:100%; border:2px solid #1a5276; margin:1em 0;"		{\| class="wikitable" style="width:100%; border:2px solid #1a5276; margin:1em 0;"

MesotheliomaSupport: Internal linking: added 2 wiki links

2026-02-20T21:02:23Z

Internal linking: added 2 wiki links

← Older revision		Revision as of 21:02, 20 February 2026
Line 43:		Line 43:
	== Executive Summary ==		== Executive Summary ==

	Asbestos-related diseases remain a major global public health burden, with an estimated 184,000 lung cancer deaths attributed to asbestos exposure worldwide each year. Because latency periods between first exposure and disease onset span 20 to 50 years, systematic screening and medical surveillance programs are essential for early detection in at-risk populations. The United States maintains a dual framework of mandatory OSHA workplace surveillance for currently exposed workers and voluntary screening programs for former workers, supplemented by emerging biomarker-based approaches and international models that continue to refine best practices.<ref name="pmc_ldct_screening" /><ref name="osha_surveillance" /><ref name="dandell_exposure" />		Asbestos-related diseases remain a major global public health burden, with an estimated 184,000 lung cancer deaths attributed to [[Asbestos Exposure\|asbestos exposure]] worldwide each year. Because latency periods between first exposure and disease onset span 20 to 50 years, systematic screening and medical surveillance programs are essential for early detection in at-risk populations. The United States maintains a dual framework of mandatory OSHA workplace surveillance for currently exposed workers and voluntary screening programs for former workers, supplemented by emerging biomarker-based approaches and international models that continue to refine best practices.<ref name="pmc_ldct_screening" /><ref name="osha_surveillance" /><ref name="dandell_exposure" />

	Low-dose computed tomography (LDCT) has demonstrated remarkable efficacy in detecting early-stage lung cancer among asbestos-exposed workers. The only mortality follow-up study conducted specifically in an asbestos-exposed population found a 59% reduction in lung cancer mortality with LDCT screening compared to chest X-ray surveillance. The DOE Former Worker Medical Screening Program — the largest organized screening effort for asbestos-exposed workers in the United States — has conducted nearly 40,000 medical screening examinations since 1996, detecting early-stage cancer in 73% of screen-identified lung cancer cases.<ref name="oup_ldct_mortality" /><ref name="cpwr_btmed" /><ref name="mlc_asbestos" />		Low-dose computed tomography (LDCT) has demonstrated remarkable efficacy in detecting early-stage lung cancer among asbestos-exposed workers. The only mortality follow-up study conducted specifically in an asbestos-exposed population found a 59% reduction in lung cancer mortality with LDCT screening compared to chest X-ray surveillance. The DOE Former Worker Medical Screening Program — the largest organized screening effort for asbestos-exposed workers in the United States — has conducted nearly 40,000 medical screening examinations since 1996, detecting early-stage cancer in 73% of screen-identified lung cancer cases.<ref name="oup_ldct_mortality" /><ref name="cpwr_btmed" /><ref name="mlc_asbestos" />

	A 27-year Italian health surveillance study of 1,405 former asbestos-exposed workers diagnosed asbestos-related diseases in 24% of the cohort, with average latency periods of 38 years for pleural plaques, 39 years for mesothelioma, 41 years for asbestosis, and 46 years for lung cancer. These findings underscore the critical importance of decades-long follow-up for exposed individuals. Current expert consensus recommends LDCT screening for workers aged 50 or older with at least 5 years of significant asbestos exposure beginning 20 or more years prior, combined with either a smoking history or additional risk factors — criteria that capture substantially more occupational lung cancers than smoking-based guidelines alone.<ref name="pmc_italian_surveillance" /><ref name="mesonet_exposure" /><ref name="dandell_diagnosis" />		A 27-year Italian health surveillance study of 1,405 former asbestos-exposed workers diagnosed asbestos-related diseases in 24% of the cohort, with average latency periods of 38 years for pleural plaques, 39 years for [[Mesothelioma\|mesothelioma]], 41 years for asbestosis, and 46 years for lung cancer. These findings underscore the critical importance of decades-long follow-up for exposed individuals. Current expert consensus recommends LDCT screening for workers aged 50 or older with at least 5 years of significant asbestos exposure beginning 20 or more years prior, combined with either a smoking history or additional risk factors — criteria that capture substantially more occupational lung cancers than smoking-based guidelines alone.<ref name="pmc_italian_surveillance" /><ref name="mesonet_exposure" /><ref name="dandell_diagnosis" />

	{\| class="wikitable" style="width:100%; border:2px solid #1a5276; margin:1em 0;"		{\| class="wikitable" style="width:100%; border:2px solid #1a5276; margin:1em 0;"

MesotheliomaSupport: Create comprehensive screening programs page: OSHA surveillance, LDCT, DOE BTMed, biomarkers, international programs

2026-02-20T04:59:51Z

Create comprehensive screening programs page: OSHA surveillance, LDCT, DOE BTMed, biomarkers, international programs

Show changes